Main CellSecondary CellSecondary CellSecondary CellBlur CellBlur CellBlur CellBlur CellBlur Cell

Our Science

We are led by experienced biopharma executives with exceptional track records of building strong companies, delivering innovative treatments and growing diverse teams.

Leaders in Immunology
Our Philosophy

Leaders in Immunology

We are led by a team of veteran biopharma executives who bring exceptional track records of developing and commercializing transformative therapies.

The Right Blend
The Right Blend

We have the right blend of experience, along with a broad network of contacts, needed to advance programs that can dramatically transform patients’ lives.

Why ACELYRIN
Why ACELYRIN

We are building a different kind of biopharma company focused on developing and delivering therapeutics through efficient and ongoing collaboration.

Our Network
Our Network

ACELYRIN can access promising therapeutic programs through our global network of relationships across pharma and biotech, finance and academia.

Our Focus
Our Focus

We conduct a licensing and acquisition search process that is both directed and opportunistically focused on platforms, programs and products when compelling science or data exist.

Our Work

Accelerating Transformative Therapies

We are actively investigating the potential of izokibep and other programs in diseases where differentiated therapeutic approaches are required to address unmet patient needs.
Partnering with ACELYRIN
Partnering with ACELYRIN
Partnering with ACELYRIN

Partnering with ACELYRIN

Partnering with ACELYRINArrow white
For Investors
For Investors
For Investors

Maximizing Shareholder Value

For InvestorsArrow white